Pelvic Osteotomy Of The Total Hip Replacement

January 7, 2024 updated by: Javad Mirzazada, Van Bölge Eğitim ve Araştırma Hastanesi

Case Report: Treatment of Hip Instability After Total Hip Replacement With Pelvic Osteotomy Using A Modified Stoppa Approach

This observational study aims to learn about the outcomes in the previously operated patient and whether pelvic bone rearrangement surgery was a success.

The main question it aims to answer is:

• Should the investigators perform pelvic rearrangement surgery on a patient if there's not enough bone stock to accomplish the exchange of the components?

As the research started the participant was asked to attend outpatient clinics regularly and keep in touch. The investigators were able to observe the outcomes and closely explore probable risks for failure.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A 56-year-old female patient had a hip operation one year previously and experienced her first dislocation two months postoperatively. The patient underwent closed reduction three times. The patient presented to us due to a fourth hip dislocation that had occurred one month previously. Hip X-ray images revealed acetabular component malposition, with an 80-degree inclination and 20 degrees of cup anteversion with a posterior hip dislocation. The investigators treated the patient via pelvic osteotomy, using a modified Stoppa approach to reduce acetabular inclination. The patient had no dislocation at the 2-year follow-up. At the last follow-up, the Harris Hip Score was 85.

Study Type

Observational

Enrollment (Actual)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • VAN, Turkey, 65035
        • VanBEAH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Since this is a single-case observational study, a population description could not be made.

Description

Inclusion Criteria:

  • Previously Replaced Total Hip
  • Minimum 1-year follow-up
  • 18-45 years, both sexes
  • otherwise healthy

Exclusion Criteria:

  • Any debilitating disorder
  • Neurological or genetic disorders
  • Pediatric or geriatric age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Harris Hip Score
Time Frame: 3 years
Higher scores, the better.
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Score
Time Frame: 3 years
Lower the scores, the better.
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Van Bölge Eğitim ve Araştırma Hastanesi

Investigators

  • Principal Investigator: Mehmet Coskun, MD, Physician

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 11, 2020

Primary Completion (Actual)

August 11, 2021

Study Completion (Actual)

August 11, 2023

Study Registration Dates

First Submitted

December 4, 2023

First Submitted That Met QC Criteria

January 7, 2024

First Posted (Actual)

January 17, 2024

Study Record Updates

Last Update Posted (Actual)

January 17, 2024

Last Update Submitted That Met QC Criteria

January 7, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VanBEAH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Osteoarthritis

Clinical Trials on Pelvic Osteotomy - Ganz Procedure

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe